Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 12/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1869757 | 1.00 | CA2 (0.47) | CA2GPR84FFAR1FFAR4LMNA | |
| SCHEMBL1805054 | 0.97 | — | — | |
| SCHEMBL1804507 | 0.88 | — | — | |
| Myristyl Alcohol SCHEMBL29081039 | 0.87 | CA2 (0.55) | CA2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL8069056 | 0.85 | CA2 (0.48) | CA2 | |
| SCHEMBL30041571 | 0.85 | CA2 (0.48) | CA2 | |
| SCHEMBL11147913 | 0.85 | CA2 (0.48) | CA2 | |
| SCHEMBL10798852 | 0.85 | CA2 (0.48) | CA2 | |
| SCHEMBL10457263 | 0.82 | CA2 (0.43) | CA2TSHR | |
| Sulfamate SCHEMBL28893196 | 0.79 | CA2 (0.53) | CA2GPR84FFAR1FFAR4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104884541-A | Polyoxazoline Copolymers | 3M INNOVATIVE PROPERTIES CO | 2015-09-02 | — | — | CN | disclosed |
| EP-2655362-A1 | HEPATITIS C INHIBITORS AND USES THEREOF | Abbvie Inc. (US) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012087833-A1 | HEPATITIS C INHIBITORS AND USES THEREOF | ABBOTT LABORATORIES (US) | 2012-06-28 | — | — | WO | disclosed |